BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19437121)

  • 1. Comorbidities, therapy, and newly diagnosed conditions for women with early stage breast cancer.
    Harlan LC; Klabunde CN; Ambs AH; Gibson T; Bernstein L; McTiernan A; Meeske K; Baumgartner KB; Ballard-Barbash R
    J Cancer Surviv; 2009 Jun; 3(2):89-98. PubMed ID: 19437121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of comorbid conditions and early-stage breast cancer therapy: linked SEER-Medicare data from 1993 to 2005.
    Yasmeen S; Chlebowski RT; Xing G; Morris CR; Romano PS
    Cancer Med; 2013 Aug; 2(4):526-36. PubMed ID: 24156025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with surgical and radiation therapy for early stage breast cancer in older women.
    Ballard-Barbash R; Potosky AL; Harlan LC; Nayfield SG; Kessler LG
    J Natl Cancer Inst; 1996 Jun; 88(11):716-26. PubMed ID: 8637025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors.
    Anwar SL; Cahyono R; Prabowo D; Avanti WS; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T
    BMC Cancer; 2021 May; 21(1):590. PubMed ID: 34022845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for the development of uterine cancer in breast cancer survivors: an army of women study.
    Torres D; Myers JA; Eshraghi LW; Riley EC; Soliman PT; Milam MR
    Ann Surg Oncol; 2015; 22(6):1974-9. PubMed ID: 25361886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of comorbidities in women with and without breast cancer in Soweto, South Africa: Results from the SABC study.
    Ayeni OA; Joffe M; Cubasch H; Rinaldi S; Taljaard C; Vorster E; Romieu I; Norris SA
    S Afr Med J; 2019 Mar; 109(4):264-271. PubMed ID: 31084693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for self-reported arm lymphedema among female breast cancer survivors: a prospective cohort study.
    Togawa K; Ma H; Sullivan-Halley J; Neuhouser ML; Imayama I; Baumgartner KB; Smith AW; Alfano CM; McTiernan A; Ballard-Barbash R; Bernstein L
    Breast Cancer Res; 2014 Aug; 16(4):414. PubMed ID: 25145603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.
    Freedman G; Fowble B; Hanlon A; Nicolaou N; Fein D; Hoffman J; Sigurdson E; Boraas M; Goldstein L
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1005-15. PubMed ID: 10421533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
    Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
    JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptoms after breast cancer treatment: are they influenced by patient characteristics?
    Yoon J; Malin JL; Tao ML; Tisnado DM; Adams JL; Timmer MJ; Ganz PA; Kahn KL
    Breast Cancer Res Treat; 2008 Mar; 108(2):153-65. PubMed ID: 17492377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment.
    Dialla PO; Dabakuyo TS; Marilier S; Gentil J; Roignot P; Darut-Jouve A; Poillot ML; Quipourt V; Arveux P
    BMC Cancer; 2012 Oct; 12():472. PubMed ID: 23066863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality impact of less-than-standard therapy in older breast cancer patients.
    Yood MU; Owusu C; Buist DS; Geiger AM; Field TS; Thwin SS; Lash TL; Prout MN; Wei F; Quinn VP; Frost FJ; Silliman RA
    J Am Coll Surg; 2008 Jan; 206(1):66-75. PubMed ID: 18155570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.
    Jordan JH; Thwin SS; Lash TL; Buist DS; Field TS; Haque R; Pawloski PA; Petersen HV; Prout MN; Quinn VP; Yood MU; Silliman RA; Geiger AM
    Breast Cancer Res Treat; 2014 Jul; 146(2):401-9. PubMed ID: 24939060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of comorbidity on primary care use during breast cancer chemotherapy: a population-based retrospective cohort study using CanIMPACT data.
    Walsh RL; Lofters AK; Moineddin R; Krzyzanowska MK; Grunfeld E
    CMAJ Open; 2021; 9(2):E331-E341. PubMed ID: 33795223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
    Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
    J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival.
    Schonberg MA; Marcantonio ER; Li D; Silliman RA; Ngo L; McCarthy EP
    J Clin Oncol; 2010 Apr; 28(12):2038-45. PubMed ID: 20308658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992-1995.
    Richardson LC; Schulman J; Sever LE; Lee NC; Coate RJ
    Breast Cancer Res Treat; 2001 Sep; 69(2):133-42. PubMed ID: 11759819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of comorbidities and age on risk of death without recurrence: a retrospective analysis of the Arimidex, Tamoxifen Alone or in Combination trial.
    Ring A; Sestak I; Baum M; Howell A; Buzdar A; Dowsett M; Forbes JF; Cuzick J
    J Clin Oncol; 2011 Nov; 29(32):4266-72. PubMed ID: 21990403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic, tumour, and treatment characteristics of female patients with breast cancer in Sri Lanka; results from a hospital-based cancer registry.
    Wijeratne DT; Gunasekera S; Booth CM; Promod H; Jalink M; Jayarajah U; Seneviratne S
    BMC Cancer; 2021 Nov; 21(1):1175. PubMed ID: 34732162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis.
    Ong CT; Ren Y; Thomas SM; Stashko I; Hyslop T; Kimmick G; Blitzblau RC; Hwang ES; Grimm LJ; Greenup RA
    Breast Cancer Res Treat; 2020 Jul; 182(2):439-449. PubMed ID: 32468334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.